BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17434173)

  • 21. Protein- versus peptide fractionation in the first dimension of two-dimensional high-performance liquid chromatography-matrix-assisted laser desorption/ionization tandem mass spectrometry for qualitative proteome analysis of tissue samples.
    Melchior K; Tholey A; Heisel S; Keller A; Lenhof HP; Meese E; Huber CG
    J Chromatogr A; 2010 Oct; 1217(40):6159-68. PubMed ID: 20810122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
    Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
    J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and identification of potential biomarkers of papillary thyroid carcinoma.
    Fan Y; Shi L; Liu Q; Dong R; Zhang Q; Yang S; Fan Y; Yang H; Wu P; Yu J; Zheng S; Yang F; Wang J
    Mol Cancer; 2009 Sep; 8():79. PubMed ID: 19785722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coupling capillary high-performance liquid chromatography to matrix-assisted laser desorption/ionization mass spectrometry and N-terminal sequencing of peptides via automated microblotting onto membrane substrates.
    Stevenson TI; Loo JA; Greis KD
    Anal Biochem; 1998 Sep; 262(2):99-109. PubMed ID: 9750124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemically-assisted fragmentation combined with multi-dimensional liquid chromatography and matrix-assisted laser desorption/ionization post source decay, matrix-assisted laser desorption/ionization tandem time-of flight or matrix-assisted laser desorption/ionization tandem mass spectrometry for improved sequencing of tryptic peptides.
    Flensburg J; Tangen A; Prieto M; Hellman U; Wadensten H
    Eur J Mass Spectrom (Chichester); 2005; 11(2):169-79. PubMed ID: 16046801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative identification of prostanoid inducible proteins by LC-ESI-MS/MS and MALDI-TOF mass spectrometry.
    Person MD; Lo HH; Towndrow KM; Jia Z; Monks TJ; Lau SS
    Chem Res Toxicol; 2003 Jun; 16(6):757-67. PubMed ID: 12807359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection and identification of specific serum biomarkers in papillary thyroid cancer].
    Wang JX; Dong R; Liu QL; Yang SB; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):265-8. PubMed ID: 19615280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward high sequence coverage of proteins in human breast cancer cells using on-line monolith-based HPLC-ESI-TOF MS compared to CE MS.
    Yoo C; Pal M; Miller FR; Barder TJ; Huber C; Lubman DM
    Electrophoresis; 2006 Jun; 27(11):2126-38. PubMed ID: 16637017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.
    Xue A; Gandy RC; Chung L; Baxter RC; Smith RC
    Pancreatology; 2012; 12(2):124-9. PubMed ID: 22487522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarker identification in human pancreatic cancer sera.
    Hanas JS; Hocker JR; Cheung JY; Larabee JL; Lerner MR; Lightfoot SA; Morgan DL; Denson KD; Prejeant KC; Gusev Y; Smith BJ; Hanas RJ; Postier RG; Brackett DJ
    Pancreas; 2008 Jan; 36(1):61-9. PubMed ID: 18192883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Separation of six uremic middle molecular compounds by high performance liquid chromatography and analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chu J; Yuan Z; Liu X; Wu Q; Mi H; He B
    Clin Chim Acta; 2001 Sep; 311(2):95-107. PubMed ID: 11566169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capillary column chromatography improves sample preparation for mass spectrometric analysis: complete characterization of human alpha-enolase from two-dimensional gels following in situ proteolytic digestion.
    Reid GE; Rasmussen RK; Dorow DS; Simpson RJ
    Electrophoresis; 1998 May; 19(6):946-55. PubMed ID: 9638941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and characterization by high-performance liquid chromatography and mass spectrometry of two truncated goat alphas2-caseins.
    Cunsolo V; Muccilli V; Saletti R; Marletta D; Foti S
    Rapid Commun Mass Spectrom; 2006; 20(7):1061-70. PubMed ID: 16617471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoelectric focusing nonporous silica reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry: a three-dimensional liquid-phase protein separation method as applied to the human erythroleukemia cell-line.
    Wall DB; Kachman MT; Gong SS; Parus SJ; Long MW; Lubman DM
    Rapid Commun Mass Spectrom; 2001; 15(18):1649-61. PubMed ID: 11555863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
    Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
    Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
    Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers.
    Wang H; Kachman MT; Schwartz DR; Cho KR; Lubman DM
    Proteomics; 2004 Aug; 4(8):2476-95. PubMed ID: 15274142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.
    Koomen JM; Zhao H; Li D; Nasser W; Hawke DH; Abbruzzese JL; Baggerly KA; Kobayashi R
    Rapid Commun Mass Spectrom; 2005; 19(12):1624-36. PubMed ID: 15915451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.